Literature DB >> 1612785

Fibroblast-dependent tumorigenicity of melanoma xenografts in athymic mice.

M F Gärtner1, E L Wilson, E B Dowdle.   

Abstract

Two human melanoma cell lines, UCT-Mel 2 and UCT-Mel 3, were invariably tumorigenic in nude mice when inoculated s.c. in doses of 10(6) cells or higher; 10(5) cells or less did not give rise to tumours. In this report we show that otherwise sub-tumorigenic inocula developed into vigorously growing tumour xenografts when co-inoculated with normal fibroblasts. Fibroblasts derived from adult, neonatal or embryonic tissues all functioned as complementing cells, as did cells of human or murine origin. There was, however, a requirement for complementing cell viability, since ethanol-killed fibroblasts were inefficacious. The fibroblast effect was dose-dependent and was not observed if injections of fibroblasts and melanoma cells were separated anatomically or temporally. We have shown, by titrating admixtures of melanoma cells and fibroblasts, that fibroblasts are, in quantitative terms, more efficacious than melanoma cells as complementing cells. The system we describe provides a useful model for the study of stromal-cell regulation of tumour growth.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612785     DOI: 10.1002/ijc.2910510520

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth.

Authors:  Victoria T Fabris; Ana Sahores; Silvia I Vanzulli; Lucas Colombo; Alfredo A Molinolo; Claudia Lanari; Caroline A Lamb
Journal:  BMC Cancer       Date:  2010-06-16       Impact factor: 4.430

2.  Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts.

Authors:  A Noël; M C De Pauw-Gillet; G Purnell; B Nusgens; C M Lapiere; J M Foidart
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

3.  Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas.

Authors:  T Ohta; M Yamamoto; M Numata; S Iseki; Y Tsukioka; T Miyashita; M Kayahara; T Nagakawa; I Miyazaki; K Nishikawa; Y Yoshitake
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.